Filters Sort results
Reset Apply
Cell Line | Cell Line Alias | Cell Type | Disease | Genetic Alteration/Mutation | Sex | Age at Collection | Ethnicity | Genetically Related Cell Lines | dbGaP Data |
|---|---|---|---|---|---|---|---|---|---|
Human iPS | Male | 61-70 Years | Caucasian | No | Yes | ||||
Human iPS | Female | 71-80 Years | Caucasian | No | Yes | ||||
Human iPS | Female | 71-80 Years | Caucasian | No | Yes | ||||
Human iPS | Female | 61-70 Years | Caucasian | No | Yes | ||||
Human iPS | Female | 81-90 Years | Caucasian | No | Yes | ||||
GCT 27 C-4 | Embryonal Carcinoma | Nonseminomatous Germ Cell Tumor | Male | 28 Years | Caucasian | No | No | ||
Embryonal Carcinoma | Nonseminomatous Germ Cell Tumor | Male | 28 Years | Caucasian | No | No | |||
R416 | Modified Human iPS | None reported | Mutated allele corrected using CRISPR/Cas9 | Male | 8 Years | No | No | ||
W416 | Human iPS | Alexander disease (Type II) | C->T transition results in mutation at amino acid residue 416. | Male | 8 Years | No | No | ||
C88 | Human iPS | Alexander disease (Type II) | C->T transition results in mutation at amino acid residue 88. | Male | 5 Years | No | No |